Company / Working Capital
Boston Scientific Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$3.4B
FY2025
5-year range
$521.0M / $3.4B
FY2021-FY2025
Trend
+544.0%
vs FY2024
Sector context
#15 of 160
Health Care
What the data says
Working Capital changed +544% YoY in FY2025, a notable deviation from the 9-year average annual change of +224%.
Based on SEC 10-K filings.
$3.4B in FY2025 with a 5-year CAGR of +2.2%. Top quartile in the Health Care sector.
Improved from $1.6B to $3.4B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +19.7%
- 5-Year CAGR
- +2.2%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 160This company $3.4B Sector average $757.1M
▼
+343.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +2.2%, indicating consistent growth.
- In FY2025, working capital increased 544.0% year-over-year.
- Ranks #15 out of 160 companies in the Health Care sector.
- Lowest working capital in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.4B | +544.0% |
| FY2024 | $521.0M | -67.0% |
| FY2023 | $1.6B | -19.2% |
| FY2022 | $2.0B | -4.2% |
| FY2021 | $2.0B | -32.2% |
| FY2020 | $3.0B | +1904.2% |
| FY2019 | -$167.0M | +86.7% |
| FY2018 | -$1.3B | +31.4% |
| FY2017 | -$1.8B | -426.4% |
| FY2016 | -$348.0M | -133.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026